Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Class II-associated invariant chain peptide (CLIP) is a peptide fragment derived from the CD74 protein that occupies the antigen-binding groove of MHC class II molecules during their intracellular assembly and transport [3, 12]. In healthy physiological states, CLIP is typically exchanged for exogenous antigenic peptides by the chaperone HLA-DM before the MHC II complex is presented on the cell surface to CD4+ T cells [3, 7]. However, in various pathological conditions—including preeclampsia, certain cancers, and autoimmune disorders—CLIP remains bound to MHC II and is expressed on the cell surface [2, 5]. This ectopic surface expression of CLIP serves as a ligand for specific subsets of gamma delta (γδ) T cells, which can trigger pro-inflammatory cascades or contribute to immune dysfunction [1, 2]. Therapeutic interventions, such as the competitive antagonist peptide VG1177, aim to displace CLIP from the MHC II groove to prevent the activation of pathogenic γδ T cells and restore immune homeostasis [2, 13]. Modulating this interaction represents a novel approach for treating inflammatory and immune-mediated diseases by targeting the transition between innate and adaptive immunity [1, 6].
Competitive inhibition of CLIP binding to the MHC class II groove, leading to the displacement of CLIP and subsequent modulation of gamma delta T cell and regulatory T cell (Treg) activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class II-associated invariant chain peptide (CLIP) (CLIP).